An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)

ABSTRACT: This prospective, multicenter, observational study will investigate the effectiveness and safety of bevacizumab in routine clinical practice in participants with metastatic CRC. Participants are to have initiated first-line treatment with fluoropyrimidine-based doublet chemotherapy plus bevacizumab according to the bevacizumab Summary of Product Characteristics (SmPC).

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2179410 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR